Oxan, Queda De Testo X Aumento De Força E Compostos

[planeta 5554]

vendo alguns relatos de oxan me parece que a queda de testo e libido talvez NA prática seja um mito...

em laboratório, depois de tomar a oxan, realmente a testo cai, os estudos indicam isso.

porém oxan dá aumento de força e se o atleta faz compostos, com essa força extra, isso provavelmente vai manter a testo alta, ou até levar a níveis mais altos que os anteriores, porque como todos sabem, compostos elevam a testo, e imagino que quanto mais força se faz, mais a testo se eleva.

pensei isso ontem, me parece muito plausível...

o que acham?

[Ribéry 15]

como q eh mito se o cara faz o exame e demonstra queda da testosterona? Viajou legal.

[mrleonardi 13]

planeta meu velho para de ter medo kkkkk cicla logo e pronto maninho

[planeta 5554]

como q eh mito se o cara faz o exame e demonstra queda da testosterona? Viajou legal.

issoae, comenta sem saber o protocolo hauheauhe

Editado Junho 26, 2013 às 14:56 por planeta

[melolucas 73]

como q eh mito se o cara faz o exame e demonstra queda da testosterona? Viajou legal.

[planeta 5554]

preciso responder de novo?

vcs nem sabem como foi o protocolo do exame

[planeta 5554]

o estudo que se baseiam pra falar que oxan baixa testo é esse:

é uma mulecada com deficiencia de crescimento

The effects of oxandrolone on the growth hormone and gonadal axes in boys with constitutional delay of growth and puberty.

Malhotra A, Poon E, Tse WY, Pringle PJ, Hindmarsh PC, Brook CG.

Source

Endocrine Unit, Middlesex Hospital, London, UK.

Abstract

OBJECTIVE:

We studied the effects of oxandrolone on serum concentrations of LH, FSH, testosterone, GH, SHBG, DHEAS, IGF-I and insulin in boys with constitutional delay of growth and puberty.

DESIGN:

Ten boys with constitutional delay of growth and puberty, mean age 13.8 years (range 12.4-15.5) were studied. Twenty-four-hour serum concentration profiles of GH, LH and FSH were constructed by drawing blood samples at 20-minute intervals. Three study occasions over a period of 6 months were chosen to assess hormone concentrations before, during and 6 weeks after a 3-month course of oxandrolone (2.5 mg once daily) therapy.

RESULTS:

Growth velocity increased during oxandrolone treatment and stayed higher after therapy (pre 3.9 +/- 0.5; on 6.3 +/- 0.8; post 6.4 +/- 0.9 cm/year (mean +/- SEM) two way ANOVA, F = 5.3, P = 0.02). Oxandrolone had androgenic effects, suppressing mean serum LH concentrations from 1.7 +/- 0.3 to 1.1 +/- 0.2 U/I and serum testosterone concentrations from 1.9 +/- 0.6 to 0.8 +/- 0.1 nmol/l. SHBG concentrations were also reduced from 130.9 +/- 14.6 to 30.7 +/- 7.3 nmol/l. Serum GH concentration fell slightly from 5.9 +/- 0.6 to 4.8 +/- 0.5 mU/l. After cessation of treatment, there was a significant 'rebound' in mean 24-hour serum LH (2.6 U/l +/- 0.4) and testosterone concentrations (3.2 +/- 0.9 nmol/l) but no change in serum GH concentrations. SHBG values also rose but not to the same extent as those observed before therapy (82.0 +/- 8.4 nmol/l). There were no statistically significant differences in serum concentrations of FSH, DHEAS, IGF-I and insulin over the study period. In a stepwise multiple regression analysis of factors that might influence the growth rate observed, the 24-hour mean serum testosterone concentration and the treatment (on or off) with oxandrolone were the main influences. The relationship was described by the equation Height velocity = 0.69 (24-hour mean serumtestosterone concentration)+1.70 (treatment regimen)+3.37 (adjusted R2 = 0.35, F = 8.39, P = 0.001).

CONCLUSIONS:

Oxandrolone has an androgenic action as shown by changes in serum LH, testosterone and SHBG concentrations and by the lack of effect on FSH. No effect of oxandrolone on the GH axis was documented. We suggest that the growth promoting effects of oxandrolone are related in part to the mild androgenic effects of the steroid and the growth acceleration following oxandrolone withdrawal may reflect increasing total serumtestosterone concentrations and decreasing levels of SHBG and progress in puberty.

http://www.ncbi.nlm.nih.gov/pubmed/9135704

esse outro é meio contraditório ao anterior pois mostra elevação na hora e queda depois

Effect of low dose oxandrolone and testosterone treatment on the pituitary-testicular and GH axes in boys with constitutional delay of growth and puberty.

Crowne EC, Wallace WH, Moore C, Mitchell R, Robertson WH, Holly JM, Shalet SM.

Source

Department of Endocrinology, Christie Hospital Trust, Manchester, UK.

Abstract

OBJECTIVE:

To investigate the effect of low dose oxandrolone and testosterone on the pituitary-testicular and GH-IGF-I axes.

DESIGN:

Prospective double-blind placebo-controlled trial.

PATIENTS:

Sixteen boys with constitutional delay of growth and puberty (CDGP) with testicular volumes 4-6 ml were randomized to 3 months treatment: Group 1 (n = 5), daily placebo: Group 2 (n = 5), 2.5 mg oxandrolone daily or Group 3 (n = 6), 50 mg testosterone monthly intramuscular injections with assessment (growth, pubertal development and overnight hormone profiles) at 0, 3, 6 and 12 months.

MAIN OUTCOME MEASURES:

LH and GH profiles (15-minute samples) were analysed by peak detection (Pulsar), Fourier transformation and autocorrelation. Testosterone levels were measured hourly and insulin, SHBG, IGF-I, and IGFBP-3 levels at 0800 h. Statistical analysis was by multivariate analysis of variance for repeated measures.

RESULTS:

LH and testosterone parameters increased significantly with time in all 16 (LH AUC, P < 0.001; peak amplitude, P = 0.02; number of peaks, P = 0.02; testosterone AUC, P = 0.02; morning testosterone, P = 0.002). In Group 2, however, LH and testosterone parameters decreased at 3 months followed by a rebound increase at 6 and 12 months. SHBG levels were markedly reduced at 3 months (P = 0.006) and a wider range of dominant GH frequencies was present although GH AUC was not increased until 6 months, with an increase in GH pulse frequency but not amplitude. IGF-I levels were increased at both 3 and 12 months. In Group 3, pituitary-testicular suppression was not apparent, but GH levels increased with an increase in GH amplitude at 3 and 12 months.

CONCLUSION:

Oxandrolone transiently suppressed the pituitary-testicular axis and altered GH pulsatility. Testosterone increased GH via amplitude modulation.

http://www.ncbi.nlm.nih.gov/pubmed/9135704

resumindo, besteira, se cair é pouco, e puxando ferro com força vai subir de volta... compostos são fodões

Editado Junho 26, 2013 às 15:50 por planeta

[ImFool 80]

kkkkkkkkkkkkkkkk, velho mete um ciclo básico de começo

ou se quiser secar de vdd, vai de EC, AEJ, talvez clemb (vc tava tomando não? oO) e uma dieta low carb, que dps de 1 ano já nen vai parecer a mesma pessoa..enqnto isso vc pesquisa mais sobre o ciclo

[planeta 5554]

to tomando clemb hoje, é 4ml, faltam 6 dias.

to fazendo dieta manutenção ... quero ver se diminue bf

depois vou fazer 15 dias de oxan a 40mg por dia, quero apenas testar os efeitos, vou tentar fazer exame de testo antes e depois, ver se aumenta força, se muda algo na aparência, se muda peso, se muda BF ... vou me pesar naquelas bioimpedância 3x antes e 3x depois, mesma hora do dia, mesma quantidade de água no corpo, tentar ir com a mesma retenção, etc

3x pra fazer a média... deve diminuir a margem de erro

e acho que precisa de tpc nenhuma essa coisa não

Editado Junho 26, 2013 às 17:26 por planeta

[Aliago 192]

Po planeta vc tá bolado com essa oxan hein? kkkk
Manda logo um ciclão básico pra dentro...

1-8 500mg enantato
1-8 60mg oxan

melhor ciclo pra ver como seu corpo reage as drogas, esqueça esses 15 dias on...

Quanto a pergunta do tópico;

Sim a forca aumenta e vc aumenta os pesos até o final do ciclo, porem a testo visivelmente diminui, depois da 5~6 semana vc comeca a se sentir mto exausto, desanimado

eu joguei no cutting:
1-6 60 mg oxan

e meu exame de testo total depois do ciclo deu 182 ng/dl

oxan sem testo nunca mais...

abraco.